Probiotix Health Ltd. logo

Probiotix Health Ltd. (X90)

Market Open
12 Aug, 07:56
XFRA XFRA
0. 08
0
0%
11.83M Market Cap
0 P/E Ratio
- Div Yield
2,218 Volume
0 Eps
0.08
Previous Close
Add Transaction
Day Range
0.08 0.09
Year Range
0.04 0.09
Want to track X90 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

X90 trading today higher at €0.08, an increase of 0% from yesterday's close, completing a monthly increase of 12.766% or €0.01. Over the past 12 months, X90 stock gained 14.3885%.
X90 is not paying dividends to its shareholders.
The last earnings report, released on Sep 08, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

X90 Chart

People also search for

DCV
Advanex Inc.
13.2
-2.9412%
OKYO Pharma Limited
1.36
0%
78W
Modulight Oyj
1.04
-0.9524%
3NQ
Nano mRNA Co., Ltd.
0.55
0%
PGT
StrongPoint ASA
0.84
-0.4751%

Probiotix Health Ltd. (X90) FAQ

What is the stock price today?

The current price is €0.08.

On which exchange is it traded?

Probiotix Health Ltd. is listed on XFRA.

What is its stock symbol?

The ticker symbol is X90.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 11.83M.

Has Probiotix Health Ltd. ever had a stock split?

No, there has never been a stock split.

Probiotix Health Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Steen Dannemann Andersen CEO
XFRA Exchange
GB00BLNBFR86 ISIN
United Kingdom Country
8 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

ProBiotix Health Plc is a pioneering company that focuses on the development of probiotics aimed at combating cardiovascular diseases and other lifestyle-related conditions. Initially established as ProBiotix Health Limited, the company transitioned to its current name, ProBiotix Health Plc, in February 2022, marking a significant phase in its evolution. The inception of the company took place in 2021, and it has since then established its headquarters in Wakefield, the United Kingdom. Operating as a subsidiary of OptiBiotix Health Plc, ProBiotix Health Plc is positioned at the forefront of leveraging the potential of probiotics to enhance cardiac health and address various lifestyle diseases, leveraging scientific advances to pioneer health solutions in the probiotic sector.

Products and Services

ProBiotix Health Plc offers a range of products and services designed to leverage the health benefits of probiotics, specifically targeting lifestyle-related diseases such as cardiovascular conditions. Below is an overview of their key offerings:

  • Cardiovascular Health Probiotics - These are specially formulated probiotic supplements aimed at improving cardiovascular health. They work by targeting gut microbiota, which has been shown to have a profound effect on heart health through mechanisms such as cholesterol reduction, blood pressure regulation, and inflammation reduction. The development of these products is based on extensive research and clinical trials to ensure efficacy and safety for users.
  • Lifestyle Condition Probiotics - Beyond cardiovascular health, ProBiotix Health Plc also develops probiotics intended to mitigate the effects of other lifestyle diseases, including obesity, diabetes, and metabolic syndrome. These formulations are designed to optimize gut health, which in turn can lead to improved metabolic functioning, weight management, and overall well-being. Like their cardiovascular-focused products, these probiotics are developed following rigorous scientific research to deliver tangible health benefits.

Contact Information

Address: First Floor Zucchi Suite